Amenorrhea (Case 42)
Amy Rogstad MD
Case: A 28-year-old woman presents with amenorrhea after discontinuing her oral contraceptive pills (OCPs). She desires pregnancy but has not conceived after 9 months of unprotected intercourse with her husband. Further questioning reveals a history of menarche at 13 years of age and normal development of secondary sexual characteristics. She believes breast development began around age 11 years. The patient’s menses were initially irregular; during the first year following menarche, she had fluctuations in cycle length and intermittently light and heavy menses. By the age of 15 years, however, her menses had become regular, occurring every 28 to 30 days and lasting about 5 days. She started OCPs when she was 20 years old both for contraception and to help with premenstrual cramping and mood swings. She continued on combination estrogen-progestin OCPs until the age of 27 years. Since stopping her OCPs, she has not had any regular menstrual cycles, with only two occasions of light bleeding lasting about 2 days each.
The patient has been feeling anxious about her inability to conceive and about her absent menses. Her husband has been evaluated and has been found to have a normal semen analysis. The patient reports that she has a history of headaches that began while she was in college but have worsened in the past 2 years. Currently she has headaches almost daily that are retro-orbital, dull, and aching. She denies any recent vision problems but has noticed occasional discharge from her breasts, which sometimes has a white, milky appearance. She has maintained a stable weight and is eating a balanced diet. She has not been sleeping well for the past 3 months, which she attributes to stress, and often feels fatigued during her workday as a high school teacher. She becomes tearful during the interview, and her husband, who accompanied her to the visit, holds her hand throughout the evaluation.
Differential Diagnosis
Hypothalamic amenorrhea (HA) |
Prolactinoma |
Pituitary adenoma |
Primary ovarian insufficiency (POI) |
PCOS |
|
Hyperthyroidism |
Hypothyroidism |
Speaking Intelligently
Amenorrhea refers to the absence or abnormal cessation of the menstrual cycle. Evaluation for primary amenorrhea, the absence of menarche, should be initiated when there is failure to menstruate by 15 years of age in the presence of normal secondary sexual characteristics or within 5 years after breast development if that occurs before 10 years of age.
Secondary amenorrhea, cessation of menses after menarche that lasts 3 months or more, should be evaluated, but sometimes it should be evaluated after 1 to 2 weeks in patients with regular cycles to exclude pregnancy. Oligomenorrhea, less than nine menstrual cycles per year, also requires investigation. Pregnancy, lactation, and menopause account for about 96% to 97% of secondary amenorrhea. Of the remaining 3% to 4%, most will have one of several common causes for amenorrhea including hypothalamic-pituitary-ovarian (HPO) axis disorders, structural abnormalities, and disorders of androgen excess.
PATIENT CARE
Clinical Thinking
• In many patients with primary amenorrhea, chromosomal abnormalities or other genetic defects cause anovulation and amenorrhea.
History
Physical Examination
• An external and internal genital exam is critical in all patients presenting with amenorrhea.
• Assess secondary sexual characteristics including breast development and axillary and pubic hair.
• The exam should specifically target the findings that could signal an underlying cause. For example, short stature, dysmorphic facial features, wide-set nipples, low hairline, or low-set ears should increase suspicion for Turner syndrome, one of the more common genetic causes for amenorrhea.
Tests for Consideration
$9 |
|
$26 |
|
$45, $26 |
|
$24 |
|
• Serum prolactin: Will be increased in the setting of prolactinoma. |
$27 |
$36 |
|
$35 |
Clinical Entities | Medical Knowledge |
Hypothalamic Amenorrhea |
|
Pφ |
Amenorrhea caused by hypothalamic dysfunction probably represents a spectrum of related disorders including functional hypothalamic amenorrhea (FHA), amenorrhea in the female athlete, and amenorrhea associated with eating disorders. The precise mechanism of these disorders is not known, but all share a reduction in hypothalamic gonadotropin-releasing hormone (GnRH) production. FHA accounts for about 15% to 35% of cases of amenorrhea, making it one of the most common causes. The blunted GnRH release pattern leads to decreased FSH and LH but an increased FSH/LH ratio similar to that seen before puberty. Estradiol levels are also decreased, and patients are usually anovulatory. Leptin, an adipocyte hormone that acts as a satiety factor and a cofactor in the maturation of the reproductive system, has been implicated in the development of HA. Leptin can stimulate GnRH pulsatility and gonadotropin secretion and is decreased in patients across the spectrum of HA. |
TP |
Amenorrhea in the female athlete is part of the “female athlete triad,” which also includes disordered eating and osteoporosis. Elite athletes in sports such as gymnastics, diving, and marathon running, as well as ballet dancers, are particularly vulnerable to this triad. In these patients, body fat often is below the 10th percentile. Buy Membership for Internal Medicine Category to continue reading. Learn more here
|